Highlights
Profile claimed by owner
About
Fertility Care with Molecular Platform
Everly Bio harnesses novel multisystem molecular insights and advanced computational biology for unprecedented decision support in fertility. Infertility is a growing global issue, that affects 1 in 6 couples. The demand for fertility services has reached unprecedented levels. However, the market has been slow to innovate, with current solutions being ineffective. Everly Bio aims to revolutionize the methodology of infertility treatments, enabling shorter time to pregnancy, increasing accessibility. Combining noninvasive technology with molecular insights and AI. Our solution serves as a platform for diagnosis and intervention.
Identity
| Name | Everly Bio |
|---|---|
| Slug | everly-bio |
| Type / kind | startup |
| Source _id | 8ScFIjwFCpTc2QBFHslhzW4gsmVDszzGuLjGnZCB5DcCjeKoc8EmlW |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country | Israel |
|---|---|
| HQ country code | IL |
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Jerusalem, Israel |
Web & social
| Website | https://everly.bio |
|---|---|
| https://www.linkedin.com/company/everly-bio |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
BiologicalsArtificial Intelligence
Target customers
Healthcare & Life SciencesConsumers
Business models
B2CB2B
Tags
healthcarefertilityartificial-intelligencemachine-learningfemtech
Funding
| Total raised | $1.7M |
|---|---|
| Current stage | Pre-Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}